Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL6 anticorps (AA 256-389)

L’anticorps Souris Monoclonal anti-BCL6 a été validé pour ELISA, IHC (f) et Coat. Il convient pour détecter BCL6 dans des échantillons de Humain.
N° du produit ABIN6936495

Aperçu rapide pour BCL6 anticorps (AA 256-389) (ABIN6936495)

Antigène

Voir toutes BCL6 Anticorps
BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

Reactivité

  • 157
  • 59
  • 23
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 90
  • 65
  • 2
  • 1
Souris

Clonalité

  • 98
  • 60
Monoclonal

Conjugué

  • 77
  • 13
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Cet anticorp BCL6 est non-conjugé

Application

  • 69
  • 69
  • 40
  • 35
  • 32
  • 26
  • 18
  • 11
  • 10
  • 8
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (Formalin-fixed Sections) (IHC (f)), Coating (Coat)

Clone

BCL6-1982
  • Épitope

    • 60
    • 11
    • 11
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 256-389

    Specificité

    Recognizes a protein of 95kDa, which is identified as Bcl-6. Antibody to bcl-6 is helpful in a number of diagnostic settings: (1) In the differential diagnosis of small B-cell lymphoma. Follicular lymphoma will show bcl-6 (and CD10) positivity whereas other small B-cell lymphomas are usually negative. (2) Bcl-6 is an important prognostic marker in diffuse large B-cell lymphomas (DLBCL), where CD10, bcl-6 and MUM1/IRF4 are used to identify germinal center and activated B-cell phenotypes. (3) Bcl-6 can be valuable in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The Reed-Sternberg cells of classical Hodgkin lymphoma are bcl-6 negative whereas the large ('LH') cells of NLPHL are bcl-6 positive. In contrast, anti-Bcl-6 rarely stains mantle-cell lymphoma and MALT lymphoma.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human bcl-6 protein fragment (around aa256-389) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: ELISA (Use Ab at 2-4ug/ml for coating) (Order Ab without BSA); Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined.

    Positive_Control: Raji or Ramos cells. Tonsil or Hodgkin's lymphoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

    Autre désignation

    BCL6

    Sujet

    B-cell lymphoma 5 protein, B-Cell Lymphoma 6 Protein, BCL5, BCL6, BCL6A, cys his2 zinc finger transcription factor, Lymphoma Associated Zinc Finger Gene On Chromosome 3 (LAZ3), Zinc finger and BTB domain-containing protein 27 (ZBTB27), Zinc Finger Protein 51 (ZNF51), zinc finger transcription factor BCL6S,Bcl-6 (Follicular Lymphoma Marker)
    Cellular localisation: Nuclear

    Poids moléculaire

    95kDa

    ID gène

    604, 478588

    UniProt

    P41182

    Pathways

    Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Vous êtes ici:
Chat with us!